News About: Pharm. Industry
EGF-containing cosmetic product to be marketed
Daewoong Pharm said it would sell an EGF (epidermal growth factor)-containing functional cosmetic at the end of next month, as part of efforts to diversify its business line.
EGF, which was first discovered by Dr. ...
Herbal arthritis drug, Joins, successful in the market.
A herbal new drug, Joins tablet, was developed and marketed by SK Pharm. Co. for the treatment of arthritis about 2 years ago, now, its sale being so successfully achieved at the level of over 10 billion won within 2 ...
Bayer and GSK to hold Asia-Pacific Levitra symposium in Seoul
The third Asia-Pacific Levitra symposium, where a number of proficient urology specialists at home and abroad will attend, is scheduled to be held on September 18 in Seoul by Bayer Korea and GSK, producer of Levitra, ...
Extended survival in patients with relapsed myeloma confirmed in Phase III trial results of Velcade
In the final survival endpoint analysis in the Phase III confirmatory APEX study comparing patients receiving Velcade (bortezomib) injection to those receiving high-dose dexamethasone, Velcade produced a statistically...
Janssen Korea to market contraceptive patchJanssen Korea announced it will sell in Korea a contractive patch Evra, developed by Ortho-MaNeil Pharmaceutical Inc.
The patch contains norelgestromin and ethinylestradiol, ...
|
New antiglaucoma drug to go on sale
Allergan Korea said it will launch via its local agent Samil Pharm Lumigan (bimatoprost ophthalmic solution) 0.03%, which is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-ang...
Dong-A, SK Pharm to promote anti-impotence medication launchings
Domestic Pharmaceutical firms are expected to launch their anti-impotence drugs, possibly in 2005 and thereafter, to challenge the increasing presence of foreign-invested pharmaceutical firms, which have marked Viagra...
Factive to launch in the U. S. markets.
LG Life Science (President: Yang Heung-joon) announced that Factive, an antibacterial quinolone, would launch it's commercial release anytime soon after the U. S. FDA approval in April this year.
The market volume...
90.2% of drug wholesalers favor M&A
The majority of drug wholesalers are desious of possible merger and acquisition to defuse cut-throat competition among 1,200 wholesalers across the nation, according to the recent survey.
The survey of 41 wholesale...
Boeringer Ingelheim Korea to launch Buscopan 10 tablets as OTC
Boeringer Ingelheim Korea said that its Buscopan in packs of 10 tablets can be bought from a pharmacy without a doctor's prescription from September 13, while a larger pack size of 100 talbets is still available on pr...
